Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain

被引:0
作者
Vincenzo L’Imperio
Federico Pieruzzi
Renato Alberto Sinico
Manuela Nebuloni
Antonio Granata
Andrew Smith
Antonella Radice
Fabio Pagni
机构
[1] University of Milano-Bicocca,Department of Medicine and Surgery, Pathology
[2] San Gerardo Hospital,Nephrology Unit, Department of Medicine and Surgery
[3] University of Milano-Bicocca,Department of Biomedical and Clinical Sciences L. Sacco
[4] University of Milan,Research Center for Renal Immunopathology
[5] University of Milan,Department of Nephrology
[6] San Giovanni Di Dio Hospital,Proteomics and Metabolomics Unit, Department of Medicine and Surgery
[7] University of Milano-Bicocca,Microbiology and Virology Department
[8] San Carlo Borromeo Hospital,undefined
来源
Journal of Nephrology | 2018年 / 31卷
关键词
PLA2R; Membranous nephropathy; THSD7A;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:543 / 550
页数:7
相关论文
共 120 条
[1]  
Hsu HC(1983)Association of hepatitis B surface (HBs) antigenemia and membranous nephropathy in children in Taiwan Clin Nephrol 20 121-129
[2]  
Lin GH(1980)Membranous glomerulopathy associated with hepatitis B core antigen immune complexes in children Am J Pathol 98 29-43
[3]  
Chang MH(1978)Strong association between membranous nephropathy and hepatitis-B surface antigenaemia in Japanese children Lancet 2 1065-1068
[4]  
Chen CH(1979)Membranous glomerulonephritis with extra-renal disorders in children Medicine (Baltimore) 58 219-228
[5]  
Slusarczyk J(2014)Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy Nephron Clin Pract 128 232-237
[6]  
Michalak T(1995)A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy Kidney Int 48 1600-1604
[7]  
Nazarewicz-de Mezer T(1998)Oral cyclophosphamide versus chlorambucil in the treatment of patients with membranous nephropathy and renal insufficiency QJM Mon J Assoc Physicians 91 359-366
[8]  
Takekoshi Y(2013)Treatment of idiopathic membranous nephropathy Nat Rev Nephrol 9 443-458
[9]  
Tanaka M(2017)Continuing the paradigm shift in the treatment of idiopathic membranous nephropathy Nat Rev Nephrol 13 720-720
[10]  
Shida N(2016)Treatment with rituximab in idiopathic membranous nephropathy Clin Kidney J 9 788-793